Karolien Vanhove

633 total citations
17 papers, 414 citations indexed

About

Karolien Vanhove is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Karolien Vanhove has authored 17 papers receiving a total of 414 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Cancer Research and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Karolien Vanhove's work include Cancer, Hypoxia, and Metabolism (8 papers), Metabolomics and Mass Spectrometry Studies (7 papers) and Radiomics and Machine Learning in Medical Imaging (3 papers). Karolien Vanhove is often cited by papers focused on Cancer, Hypoxia, and Metabolism (8 papers), Metabolomics and Mass Spectrometry Studies (7 papers) and Radiomics and Machine Learning in Medical Imaging (3 papers). Karolien Vanhove collaborates with scholars based in Belgium, Netherlands and France. Karolien Vanhove's co-authors include Liesbet Mesotten, Peter Adriaensens, Michiel Thomeer, Wanda Guedens, Elien Derveaux, Geert‐Jan Graulus, Jean‐Paul Noben, Evelyne Louis, Ziv Shkedy and Kurt Vandeurzen and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Annals of Oncology.

In The Last Decade

Karolien Vanhove

17 papers receiving 411 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karolien Vanhove Belgium 10 248 198 87 62 55 17 414
Liesbet Mesotten Belgium 12 301 1.2× 212 1.1× 94 1.1× 64 1.0× 111 2.0× 27 521
Zahra Rattray United Kingdom 12 228 0.9× 74 0.4× 32 0.4× 70 1.1× 35 0.6× 46 422
Ziyang Wang China 14 336 1.4× 230 1.2× 132 1.5× 75 1.2× 10 0.2× 37 556
Akash Kaushik United States 6 292 1.2× 191 1.0× 56 0.6× 65 1.0× 14 0.3× 8 419
Upasana Ray United States 12 346 1.4× 185 0.9× 46 0.5× 124 2.0× 9 0.2× 19 530
Majda Haznadar United States 11 322 1.3× 161 0.8× 64 0.7× 66 1.1× 13 0.2× 19 494
Daisuke Iizuka Japan 14 217 0.9× 93 0.5× 70 0.8× 101 1.6× 106 1.9× 36 388
Lorenza Di Ianni Italy 10 301 1.2× 227 1.1× 31 0.4× 82 1.3× 12 0.2× 10 442
Igor Marín de Mas Spain 11 301 1.2× 98 0.5× 71 0.8× 44 0.7× 8 0.1× 19 475

Countries citing papers authored by Karolien Vanhove

Since Specialization
Citations

This map shows the geographic impact of Karolien Vanhove's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karolien Vanhove with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karolien Vanhove more than expected).

Fields of papers citing papers by Karolien Vanhove

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karolien Vanhove. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karolien Vanhove. The network helps show where Karolien Vanhove may publish in the future.

Co-authorship network of co-authors of Karolien Vanhove

This figure shows the co-authorship network connecting the top 25 collaborators of Karolien Vanhove. A scholar is included among the top collaborators of Karolien Vanhove based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karolien Vanhove. Karolien Vanhove is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Adriaensens, Peter, Maarten Criel, Evelyne Louis, et al.. (2024). Plasma Metabolite Profiling in the Search for Early-Stage Biomarkers for Lung Cancer: Some Important Breakthroughs. International Journal of Molecular Sciences. 25(9). 4690–4690. 1 indexed citations
2.
Derveaux, Elien, Melvin Geubbelmans, Maarten Criel, et al.. (2023). NMR-Metabolomics Reveals a Metabolic Shift after Surgical Resection of Non-Small Cell Lung Cancer. Cancers. 15(7). 2127–2127. 6 indexed citations
3.
Ruytinx, Pieter, Judith Fraussen, Niels Hellings, et al.. (2023). Comprehensive antibody and cytokine profiling in hospitalized COVID-19 patients in relation to clinical outcomes in a large Belgian cohort. Scientific Reports. 13(1). 19322–19322. 8 indexed citations
4.
Vanhove, Karolien, Elien Derveaux, Liesbet Mesotten, et al.. (2022). Unraveling the Rewired Metabolism in Lung Cancer Using Quantitative NMR Metabolomics. International Journal of Molecular Sciences. 23(10). 5602–5602. 6 indexed citations
5.
Derveaux, Elien, et al.. (2022). Changes in Metabolism as a Diagnostic Tool for Lung Cancer: Systematic Review. Metabolites. 12(6). 545–545. 9 indexed citations
6.
Byttebier, Geert, M Alexander, Bo E. H. Saxberg, et al.. (2021). Hospital mortality in COVID-19 patients in Belgium treated with statins, ACE inhibitors and/or ARBs. Human Vaccines & Immunotherapeutics. 17(9). 2841–2850. 11 indexed citations
7.
Pfaehler, Elisabeth, Liesbet Mesotten, Gem Kramer, et al.. (2021). Repeatability of two semi-automatic artificial intelligence approaches for tumor segmentation in PET. EJNMMI Research. 11(1). 4–4. 21 indexed citations
8.
Pfaehler, Elisabeth, Liesbet Mesotten, Ivan Zhovannik, et al.. (2020). Plausibility and redundancy analysis to select FDG‐PET textural features in non‐small cell lung cancer. Medical Physics. 48(3). 1226–1238. 17 indexed citations
9.
Vanhove, Karolien, Geert‐Jan Graulus, Liesbet Mesotten, et al.. (2019). The Metabolic Landscape of Lung Cancer: New Insights in a Disturbed Glucose Metabolism. Frontiers in Oncology. 9. 1215–1215. 106 indexed citations
10.
Vanhove, Karolien, Michiel Thomeer, Elien Derveaux, et al.. (2019). Correlations between the metabolic profile and 18F-FDG-Positron Emission Tomography-Computed Tomography parameters reveal the complexity of the metabolic reprogramming within lung cancer patients. Scientific Reports. 9(1). 16212–16212. 7 indexed citations
11.
Vanhove, Karolien, Elien Derveaux, Geert‐Jan Graulus, et al.. (2019). Glutamine Addiction and Therapeutic Strategies in Lung Cancer. International Journal of Molecular Sciences. 20(2). 252–252. 91 indexed citations
12.
Vanhove, Karolien, Peter Giesen, Liesbet Mesotten, et al.. (2018). The plasma glutamate concentration as a complementary tool to differentiate benign PET-positive lung lesions from lung cancer. BMC Cancer. 18(1). 868–868. 17 indexed citations
13.
Vanhove, Karolien, Liesbet Mesotten, Evelyne Louis, et al.. (2017). Prognostic value of total lesion glycolysis and metabolic active tumor volume in non-small cell lung cancer. Cancer Treatment and Research Communications. 15. 7–12. 19 indexed citations
14.
Louis, Evelyne, François‐Xavier Cantrelle, Liesbet Mesotten, et al.. (2017). Metabolic phenotyping of human plasma by 1H‐NMR at high and medium magnetic field strengths: a case study for lung cancer. Magnetic Resonance in Chemistry. 55(8). 706–713. 11 indexed citations
15.
Louis, Evelyne, Peter Adriaensens, Wanda Guedens, et al.. (2016). Detection of Lung Cancer through Metabolic Changes Measured in Blood Plasma. Journal of Thoracic Oncology. 11(4). 516–523. 59 indexed citations
16.
Louis, Evelyne, Karolien Vanhove, Liesbet Mesotten, et al.. (2015). Validation of 1H-NMR-based metabolomics as a new, complementary tool for the detection of lung cancer via human blood plasma. Document Server@UHasselt (UHasselt). 1 indexed citations
17.
Louis, Evelyne, Peter Adriaensens, Wanda Guedens, et al.. (2015). Metabolic phenotyping of human blood plasma: a powerful tool to discriminate between cancer types?. Annals of Oncology. 27(1). 178–184. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Liesbet Mesotten Breakdown of academic impact, for papers by Zahra Rattray Breakdown of academic impact, for papers by Ziyang Wang Breakdown of academic impact, for papers by Akash Kaushik Breakdown of academic impact, for papers by Upasana Ray Breakdown of academic impact, for papers by Majda Haznadar Breakdown of academic impact, for papers by Daisuke Iizuka Breakdown of academic impact, for papers by Lorenza Di Ianni Breakdown of academic impact, for papers by Igor Marín de Mas
Rankless by CCL
2026